查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1514104

全球产前诊断市场

Prenatal Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球产前诊断市场（美国）预计将达到 142 亿美元

2023年全球产前诊断市场估计为61亿美元，预计2030年将达到142亿美元，2023-2030年分析期间复合年增长率为12.7%。非侵入性检测是本报告分析的细分市场之一，预计复合年增长率为 15.2%，到分析期结束时将达到 106 亿美元。分析期间，侵入式检测领域的复合年增长率预计为 7.1%。

美国市场预计16亿美元，中国预计复合年增长率17.2%

预计 2023 年美国产前诊断市场规模将达 16 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达36亿美元，2023-2030年分析期间复合年增长率为17.2%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 8.0% 和 10.7%。在欧洲，德国的复合年增长率预计约为 9.7%。

全球产前诊断市场趋势及驱动因素总结

产前诊断已成为现代产科护理的重要组成部分，提供有关胎儿健康和状况的重要资讯。这些诊断对于管理妊娠、预测併发症以及确保胎儿和孕产妇健康至关重要。产前诊断在检测先天性异常方面发挥重要作用，先天性异常占周产期死亡的很大一部分。现有技术，从超音波检测等非侵入性方法到羊膜穿刺术和绒毛膜绒毛取样（CVS）等侵入性方法，可以进行详细评估和早期干预。这些方法使医疗保健提供者能够管理怀孕的最后几週，规划与出生相关的併发症，为潜在的新生儿问题做好准备，并就继续怀孕做出明智的决定。

无创技术，例如超音波检查，使用高频声波对胎儿和母亲的内部结构进行成像。儘管这种方法很安全，并且最早可以在怀孕 6 週时进行可视化，但其检测特定异常（例如与唐氏症相关的异常）的能力有限。母体血液取样提取胎儿 DNA 是分析母体血液中胎儿 DNA 来检测染色体异常的另一种非侵入性方法，但前提是存在足够多的胎儿才能获得准确的结果。羊膜穿刺术和 CVS 等侵入性技术透过提取胎儿细胞进行染色体、生化和分子分析来提供更详细的资讯。儘管这些手术存在相关风险，包括胎儿死亡和母体 Rh 过敏，但它们为了解胎儿的遗传和发育健康提供了重要的见解。

产前诊断的成长是由技术进步和对其益处的认识不断提高所推动的。诊断影像技术和基因检测能力的进步大大提高了产前诊断的准确性和可靠性。人工智慧 (AI) 和机器学习在这些过程中的整合进一步提高了诊断准确性，并能够及早、准确地检测潜在问题。此外，对个人化医疗和预防保健的需求不断增长，导致产前诊断技术的广泛采用。支持性法律规范、非侵入性选择的增加以及病患教育的改善也有助于扩大这些服务。随着技术的不断发展，产前诊断的范围将会扩大，为胎儿的健康提供更全面的了解，并有望为母亲和婴儿带来更好的结果。

受访企业范例（共43例）

  • ANGLE Plc
  • Berry Genomics Co. Ltd.
  • BGI Genomics
  • F. Hoffmann-La Roche Ltd.
  • Hologic Inc.
  • Illumina Inc.
  • Laboratory Corporation of America（R）Holdings
  • Lifecodexx AG
  • Natera Inc.
  • Quest Diagnostics Inc.
  • Ravgen Inc.
  • Sequenom Inc.

目录

第一章调查方法

第二章执行概述

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP-7675

Global Prenatal Diagnostics Market to Reach US$14.2 Billion by 2030

The global market for Prenatal Diagnostics estimated at US$6.1 Billion in the year 2023, is expected to reach US$14.2 Billion by 2030, growing at a CAGR of 12.7% over the analysis period 2023-2030. Non-Invasive Test, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$10.6 Billion by the end of the analysis period. Growth in the Invasive Test segment is estimated at 7.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Billion While China is Forecast to Grow at 17.2% CAGR

The Prenatal Diagnostics market in the U.S. is estimated at US$1.6 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 17.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.0% and 10.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.7% CAGR.

Global Prenatal Diagnostics Market - Key Trends & Drivers Summarized

Prenatal diagnostics have become essential in modern obstetrics, providing critical information about the health and condition of an unborn fetus. These diagnostics are vital for managing pregnancy, anticipating complications, and ensuring the well-being of both the fetus and the mother. Prenatal diagnostics play a significant role in detecting congenital anomalies, which account for a substantial percentage of perinatal deaths. The techniques available, ranging from non-invasive methods like ultrasonography to invasive procedures such as amniocentesis and chorionic villus sampling (CVS), allow for detailed assessment and early intervention. These methods enable healthcare providers to manage the final weeks of pregnancy, plan for birth-related complications, prepare for potential newborn issues, and make informed decisions regarding the continuation of the pregnancy.

Non-invasive techniques such as ultrasonography use high-frequency sound waves to create images of the fetus and internal structures of the mother. This method is safe and allows visualization as early as six weeks gestation, although its ability to detect certain abnormalities, like those associated with Down syndrome, is limited. Maternal blood sampling for fetal DNA is another non-invasive method that analyzes fetal DNA present in the mother's blood to detect chromosomal anomalies, though it can be challenging to obtain sufficient fetal DNA for accurate results. Invasive techniques like amniocentesis and CVS provide more detailed information by extracting fetal cells for chromosomal, biochemical, and molecular analysis. Despite the risks associated with these procedures, such as fetal loss and maternal Rh sensitization, they offer critical insights into the genetic and developmental health of the fetus.

The growth of prenatal diagnostics is driven by advancements in technology and increased awareness of their benefits. Enhanced imaging techniques and genetic testing capabilities have significantly improved the accuracy and reliability of prenatal diagnostics. The integration of artificial intelligence (AI) and machine learning in these processes further refines diagnostic precision, enabling earlier and more accurate detection of potential issues. Additionally, the rising demand for personalized healthcare and preventive medicine has led to broader adoption of prenatal diagnostic techniques. Supportive regulatory frameworks, increased availability of non-invasive options, and improved patient education have also contributed to the expansion of these services. As technology continues to evolve, the scope of prenatal diagnostics is expected to broaden, providing even more comprehensive insights into fetal health and facilitating better outcomes for both mothers and their babies.

Select Competitors (Total 43 Featured) -

  • ANGLE Plc
  • Berry Genomics Co. Ltd.
  • BGI Genomics
  • F. Hoffmann-La Roche Ltd.
  • Hologic Inc.
  • Illumina Inc.
  • Laboratory Corporation of America(R) Holdings
  • Lifecodexx AG
  • Natera Inc.
  • Quest Diagnostics Inc.
  • Ravgen Inc.
  • Sequenom Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Prenatal Diagnostics - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Early and Accurate Prenatal Screening Spurs Market Growth
    • Advances in Genetic Testing Technologies Propel Innovation in Prenatal Diagnostics
    • Rising Adoption of Non-Invasive Prenatal Testing (NIPT) Expands Market Potential
    • Increasing Awareness and Focus on Maternal and Fetal Health Drives Demand
    • Product Innovations and Customization Strengthen Business Case for Prenatal Diagnostics
    • Expanding Use of Prenatal Diagnostics in High-Risk Pregnancies Sustains Market Growth
    • Government Initiatives and Investments in Healthcare Infrastructure Spur Market Expansion
    • Increasing Preference for Safe and Reliable Diagnostic Procedures Drives Demand
    • Strategic Collaborations and Partnerships Strengthen Market Position for Key Players
    • Rising Awareness and Implementation of Advanced Imaging Technologies Generate Market Opportunities
    • Rising Awareness and Implementation of Advanced Imaging Technologies Generate Market Opportunities
    • Growing Adoption of Prenatal Diagnostics in Emerging Markets Propels Market Growth
    • Focus on Reducing Healthcare Costs and Improving Pregnancy Outcomes Drives Demand for Prenatal Diagnostics
    • Influence of Digital Health and Telemedicine Expands Market Reach
    • Healthcare Providers' Focus on Early Detection and Prevention Throws Spotlight on Prenatal Diagnostics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Prenatal Diagnostics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Prenatal Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Prenatal Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Prenatal Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Non-Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Non-Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Invasive by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Invasive by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Trisomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Trisomy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Trisomy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Micro-Deletions Symptoms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Micro-Deletions Symptoms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Micro-Deletions Symptoms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Canada Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: Canada 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 53: Japan Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Japan Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Japan 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: China 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: China 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: China Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: China 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Prenatal Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Prenatal Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Prenatal Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Europe 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 77: France Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: France 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: France 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 83: France Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: France Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: France 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 92: Germany Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Germany Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Germany 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 101: Italy Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Italy Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Italy 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 104: UK Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 110: UK Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: UK Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: UK 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 119: Spain Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: Spain Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: Spain 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 128: Russia Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Russia Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Russia 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Rest of Europe Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Rest of Europe 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Prenatal Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Prenatal Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Prenatal Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Asia-Pacific 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 158: Australia Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Australia Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Australia 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 161: India Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: India 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: India 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 167: India Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 168: India Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: India 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 176: South Korea Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: South Korea Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: South Korea 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Prenatal Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Prenatal Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Prenatal Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: Latin America 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 206: Argentina Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Argentina Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Argentina 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 215: Brazil Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 216: Brazil Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 217: Brazil 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 224: Mexico Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 225: Mexico Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 226: Mexico 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 234: Rest of Latin America Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 235: Rest of Latin America 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Prenatal Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Prenatal Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Prenatal Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 247: Middle East 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 254: Iran Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 255: Iran Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 256: Iran 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 263: Israel Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 264: Israel Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 265: Israel 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 273: Saudi Arabia Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 274: Saudi Arabia 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 281: UAE Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 282: UAE Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 283: UAE 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 291: Rest of Middle East Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 292: Rest of Middle East 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Prenatal Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Prenatal Diagnostics by Test Type - Non-Invasive and Invasive Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Prenatal Diagnostics by Test Type - Percentage Breakdown of Value Sales for Non-Invasive and Invasive for the Years 2014, 2024 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Prenatal Diagnostics by Application - Trisomy, Micro-Deletions Symptoms and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Prenatal Diagnostics by Application - Percentage Breakdown of Value Sales for Trisomy, Micro-Deletions Symptoms and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 299: Africa Recent Past, Current & Future Analysis for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 300: Africa Historic Review for Prenatal Diagnostics by End-Use - Diagnostic Centers, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 301: Africa 16-Year Perspective for Prenatal Diagnostics by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION